Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
JUBLPHARMA
₹891.55
₹877.60
₹928.15
₹786.05
₹1184.80
Markets Today
Historical Performance
As of 24-08-2026 11:59, Jubilant Pharmova Ltd. share price today is ₹0, with a change of ₹-880.35 (-100.00%) from the previous close of ₹880.35. The stock opened at ₹912 and traded between ₹877.6 and ₹928.15, with a total traded volume of 964251 shares. The company has a market capitalization of ₹13874.2 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1184.8 and ₹786.05, respectively.
Jubilant Pharmova Ltd. valuation metrics include a P/E ratio of 39.4, EPS of ₹25.15, and book value of ₹2.00. Profitability indicators show ROE of 5.61% along with a dividend yield of 0.6%. Jubilant Pharmova Ltd. has reported revenue of ₹8608.3 Cr and net profit of ₹352.1 Cr.
Jubilant Pharmova Ltd. technical indicators include Day RSI at 30.53, Day MFI at 38.58, Day ADX at 17.42. Additional indicators include Commodity Channel Index (CCI) at -134.8 and Williams %R at -86.31. Momentum indicators show Day MACD at -27.72, Day MACD Signal Line at -19.66, DayATR at 32.55. Rate of Change indicators for Jubilant Pharmova Ltd. include ROC125 at -4.93 and ROC21 at -13.87.
Exponential moving averages include EMA5 at ₹876.9, EMA10 at ₹895.6, EMA12 at ₹901.8, EMA20 at ₹920.4, EMA26 at ₹929.5, EMA50 at ₹945.8, EMA100 at ₹954.7, EMA200 at ₹971.8. Simple moving averages include SMA5 at ₹871.4, SMA10 at ₹903.4, SMA20 at ₹928.9, SMA30 at ₹951.7, SMA50 at ₹959.7, SMA100 at ₹950.3, SMA150 at ₹938.3, SMA200 at ₹976.9.
Support levels for Jubilant Pharmova are placed at First Support ₹855.32, Second Support ₹842.63, Third Support ₹831.92. Resistance levels are seen at First Resistance ₹878.72, Second Resistance ₹889.43, Third Resistance ₹902.12. Jubilant Pharmova Ltd. shareholding pattern shows promoter holding at 47.68%, FII holding at 15.87%, DII holding at 0%, public holding at 23.5%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 67.10 | 70.30 | 67.30 | 66.40 | 59.50 |
| Operating Expense | 55.10 | 55.80 | 55.10 | 54.60 | 49.20 |
| Operating Profit | 12 | 14.50 | 12.20 | 11.80 | 10.30 |
| Depreciation | 1.40 | 1.30 | 1.60 | 1.60 | 1.50 |
| Interest | 0.90 | 0.90 | 0.90 | 2.50 | 3 |
| Tax | 2.50 | -53.10 | 3.50 | 56.50 | 2.40 |
| Net Profit | 7.30 | 57.20 | 6.60 | -6.40 | 5.80 |
₹891.55
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 50.7 | 47.7 | 47.7 | 47.7 | 47.7 | 47.7 |
| FII | 17.2 | 17.4 | 16.6 | 16 | 15.9 | 15.9 |
| DII | 7.1 | 9.5 | 10.5 | 11.2 | 11.6 | 12.4 |
| Public | 24.5 | 24.8 | 24.6 | 24.6 | 24.2 | 23.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 7.28 L | 9.7 L | 75.10% |
| Week | 2.47 L | 3.89 L | 63.50% |
| 1 Month | 1.39 L | 2.6 L | 53.49% |
| 6 Month | 87.81 K | 1.73 L | 50.71% |
Benjamin Graham Value Screen
PEG lower than Industry PEG
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Book Value per share Improving for last 2 years
Top Gainers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 24 Jul, 2026 | 5 | FINAL | 24 Jul, 2026 | Equity Share |
| 25 Jul, 2025 | 5 | FINAL | 25 Jul, 2025 | Equity Share |
| 02 Aug, 2024 | 5 | FINAL | 02 Aug, 2024 | Equity Share |
| 10 Aug, 2023 | 5 | FINAL | 10 Aug, 2023 | Equity Share |
| 11 Aug, 2022 | 5 | FINAL | 12 Aug, 2022 | Equity Share |
| 05 Aug, 2021 | 5 | FINAL | 06 Aug, 2021 | Equity Share |
| 09 Mar, 2020 | 5 | INTERIM | 11 Mar, 2020 | Equity Share |
| 12 Sep, 2019 | 4.5 | FINAL | Equity Share | |
| 12 Sep, 2018 | 3 | FINAL | Equity Share | |
| 16 Aug, 2017 | 3 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹2,158.70 | ₹1,125.85 | ₹1,566 | ₹1,527 | ₹4,190.20 | ₹774.50 |
| % Change | 0.75% | 1.26% | 3.48% | -0.52% | -0.76% | 3.27% |
| Revenue TTM (₹ Cr) | ₹1,479.07 | ₹675.61 | ₹691.72 | ₹1,543.34 | ₹949.80 | ₹4,501.61 |
| Net Profit TTM (₹ Cr) | ₹199.03 | ₹182.64 | ₹126.37 | ₹-48.62 | ₹266 | ₹291.72 |
| PE TTM | 65.20 | 71.50 | 56.50 | -358.60 | 36.60 | 40.60 |
| 1 Year Return | 99.76 | 95.01 | 121.72 | -17.12 | -19 | 57.13 |
| ROCE | 31.54 | 24.22 | 15.60 | 0.59 | - | 11.40 |
Innova Captab Ltd.
₹ 1078.70
-0.90%
Blue Jet Healthcare Ltd
₹ 605.00
+1.48%
Concord Biotech Ltd.
₹ 1536.20
-2.23%
Aarti Pharmalabs Ltd.
₹ 843.00
+3.21%
Supriya Lifescience Ltd.
₹ 803.80
-0.20%
Alivus Life Sciences Ltd.
₹ 1346.60
-0.32%
Cohance Lifesciences Ltd.
₹ 452.20
-2.33%
Eris Lifesciences Ltd.
₹ 1313.80
-1.08%
Syngene International Ltd.
₹ 401.30
-1.46%
Alembic Pharmaceuticals Ltd.
₹ 815.00
-0.82%
Sun Pharma Advanced Research Company Ltd.
₹ 197.07
+0.18%
Strides Pharma Science Ltd.
₹ 981.30
-0.50%
FDC Ltd.
₹ 348.40
-0.06%
Shilpa Medicare Ltd.
₹ 862.35
+5.82%
Natco Pharma Ltd.
₹ 885.00
+0.29%
Caplin Point Laboratories Ltd.
₹ 2500.00
-2.37%
Marksans Pharma Ltd.
₹ 322.60
+0.40%
Orchid Pharma Ltd.
₹ 1020.50
+1.84%
Viyash Scientific Ltd.
₹ 268.60
-2.66%
AstraZeneca Pharma India Ltd.
₹ 7265.00
-2.03%
Bliss GVS Pharma Ltd.
₹ 570.50
-1.49%
Sanofi India Ltd.
₹ 3315.00
-1.13%
Morepen Laboratories Ltd.
₹ 96.40
+0.41%
Procter & Gamble Health Ltd.
₹ 5869.00
+0.69%
By signing up I certify terms, conditions & privacy policy